David J. Eschelman MD
Professor, Radiology, Sidney Kimmel Medical College of Thomas Jefferson University; Co-Director, Division of Interventional Radiology, Thomas Jefferson University Hospital
Join to View Full Profile
111 S 11th StSte 3390Philadelphia, PA 19107
Phone+1 215-955-2900
Fax+1 215-923-1562
Dr. Eschelman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Liver-directed treatments for metastatic uveal melanoma
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Vascular and Interventional Radiology, 1991 - 1993
Boston University Medical CenterResidency, Radiology-Diagnostic, 1987 - 1991- Boston University Medical CenterInternship, Surgery, 1986 - 1987
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1986
Certifications & Licensure
PA State Medical License 1990 - 2026
CT State Medical License 1994 - 1996
American Board of Radiology Interventional Radiology and Diagnostic Radiology
Awards, Honors, & Recognition
- Outstanding Clinician Award Sidney Kimmel Medical College of Thomas Jefferson University, 2024
- Top Doctor in Vascular/Interventional Radiolgy Philadelphia Magazine, 2017-2024
- Top Doctor in Vascular & Interventional Radiology Castle Connolly, 2015-2024
Clinical Trials
- TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma
- SIR-Spheres® 90Y Microspheres Treatment of Uveal Melanoma Metastasized to Liver Start of enrollment: 2011 Oct 31
- Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- Subgroup analyses of the phase 3 FOCUS study of melphalan/hepatic delivery system in patients with unresectable metastatic uveal melanoma.Jonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, Junsung Choi, David J Eschelman
Journal of Cancer Research and Clinical Oncology. 2025-12-29 - Percutaneous Hepatic Perfusion Melphalan Induced Sinusoidal Obstruction Syndrome (Veno-Occlusive Disease) in a Patient with Metastatic Uveal Melanoma.Stephan S Leung, Carin F Gonsalves, Marlana Orloff, Robert D Adamo, Christina C Lindenmeyer
Case Reports in Oncology. 2025-07-28 - 5 citationsAn Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma.Jonathan S Zager, Marlana Orloff, Pier Francesco Ferrucci, Junsung Choi, David J Eschelman
Annals of Surgical Oncology. 2025-07-01
Authored Content
- Inferior Vena Cava Filter Placement and Retrieval Rates Among Radiologists and NonradiologistsJanuary 2018
Press Mentions
Shift in Treatment Modalities Associated with Improved Outcomes in Uveal Melanoma Patients with LiveFebruary 3rd, 2020
New Ocular Melanoma Research Grant in Honor of David EschelmanMay 3rd, 2017
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
